Press Releases

Date Title and Summary View
Toggle Summary Aquinox to Present at Canaccord Genuity 37th Annual Growth Conference
VANCOUVER, British Columbia , Aug. 02, 2017 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals , Inc. (" Aquinox ") (NASDAQ:AQXP), a clinical-stage pharmaceutical company discovering and developing targeted therapeutics in disease areas of inflammation and immuno-oncology, announced today that David Main
View HTML
Toggle Summary Aquinox Pharmaceuticals to Announce Second Quarter 2017 Financial Results
Conference call Tuesday August 8, 2016 at 8:30 AM ET
View HTML
Toggle Summary Aquinox to Present at Jefferies 2017 Global Healthcare Conference
VANCOUVER, British Columbia , June 01, 2017 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals , Inc. (" Aquinox ") (NASDAQ:AQXP), a clinical-stage pharmaceutical company discovering and developing targeted therapeutics in disease areas of inflammation and immuno-oncology, announced today that David Main
View HTML
Toggle Summary Aquinox Pharmaceuticals Announces First Quarter 2017 Financial Results
VANCOUVER, British Columbia , May 09, 2017 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals , Inc. (" Aquinox ") (NASDAQ:AQXP), a clinical-stage pharmaceutical company discovering and developing targeted therapeutics in disease areas of inflammation and immuno-oncology, today provided a corporate update
View HTML
Toggle Summary Aquinox to Present at 2017 Bloom Burton & Co. Healthcare Investor Conference
VANCOUVER, British Columbia , April 25, 2017 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals , Inc. (" Aquinox ") (NASDAQ:AQXP), a clinical-stage pharmaceutical company discovering and developing targeted therapeutics in disease areas of inflammation and immuno-oncology, announced today that David Main
View HTML
Toggle Summary Aquinox to Present at the 16th Annual Needham Healthcare Conference
VANCOUVER, British Columbia , March 29, 2017 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals , Inc. (" Aquinox ") (NASDAQ:AQXP), a clinical-stage pharmaceutical company discovering and developing targeted therapeutics in disease areas of inflammation and immuno-oncology, announced today that David Main
View HTML
Toggle Summary Aquinox Announces Appointment of Dr. Kelvin Neu and Dr. Richard Levy to Board of Directors
VANCOUVER, British Columbia , March 27, 2017 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals , Inc. (" Aquinox ") (NASDAQ:AQXP), a clinical-stage pharmaceutical company discovering and developing targeted therapeutics in disease areas of inflammation and immuno-oncology, today announced that
View HTML
Toggle Summary Aquinox to Present at the Oppenheimer & Co. 27th Annual Healthcare Conference
VANCOUVER, British Columbia , March 14, 2017 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals , Inc. (" Aquinox ") (NASDAQ:AQXP), a clinical-stage pharmaceutical company discovering and developing targeted therapeutics in disease areas of inflammation and immuno-oncology, announced today that David Main
View HTML
Toggle Summary Aquinox Pharmaceuticals Announces Year End 2016 Financial Results
Conference call update today at 4:30PM ET
View HTML
Toggle Summary Aquinox Pharmaceuticals to Announce 2016 Year End Financial Results
- Conference call Thursday, March 9, 2017 at 4:30PM ET -
View HTML